AIM Archived Articles

AIM ImmunoTech Inc.: Advancing Novel Therapeutics in Immuno-Oncology and Beyond


AIM ImmunoTech Inc. (AIM): Driving Momentum Across High-Value Pipeline


AIM ImmunoTech Inc. (NYSE American: AIM): Ampligen's Promising Potential Across Multiple Indications